Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial.
Saved in:
| Title: | Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial. |
|---|---|
| Authors: | Holly T; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway., Kirkesaether Brun M; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Jørgensen KK; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Goll GL; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Sexton J; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Gehin JE; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Kvien TK; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Jahnsen J; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Provan SA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Department of Public Health and Sport Sciences, Faculty of Social and Health Sciences, University of Inland Norway, Elverum, Norway., Bolstad N; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Aas E; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Health Services Research, Norwegian Institute of Public Health, Oslo, Norway., Haavardsholm EA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Kristiansen IS; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.; Research Unit of General Practice, University of Southern Denmark, Odense, Denmark., Syversen SW; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Hagen G; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway gunhild.hagen@diakonsyk.no.; Department of Health Services Research, Norwegian Institute of Public Health, Oslo, Norway. |
| Source: | RMD open [RMD Open] 2026 Mar 19; Vol. 12 (1). Date of Electronic Publication: 2026 Mar 19. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41856561 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Holly+T%22">Holly T</searchLink>; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kirkesaether+Brun+M%22">Kirkesaether Brun M</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jørgensen+KK%22">Jørgensen KK</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Goll+GL%22">Goll GL</searchLink>; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Sexton+J%22">Sexton J</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Gehin+JE%22">Gehin JE</searchLink>; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kvien+TK%22">Kvien TK</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jahnsen+J%22">Jahnsen J</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Provan+SA%22">Provan SA</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Department of Public Health and Sport Sciences, Faculty of Social and Health Sciences, University of Inland Norway, Elverum, Norway.<br /><searchLink fieldCode="AU" term="%22Bolstad+N%22">Bolstad N</searchLink>; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Aas+E%22">Aas E</searchLink>; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Health Services Research, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Haavardsholm+EA%22">Haavardsholm EA</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kristiansen+IS%22">Kristiansen IS</searchLink>; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.; Research Unit of General Practice, University of Southern Denmark, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Syversen+SW%22">Syversen SW</searchLink>; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Hagen+G%22">Hagen G</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway gunhild.hagen@diakonsyk.no.; Department of Health Services Research, Norwegian Institute of Public Health, Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101662038%22">RMD open</searchLink> [RMD Open] 2026 Mar 19; Vol. 12 (1). <i>Date of Electronic Publication: </i>2026 Mar 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group%22">BMJ Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101662038 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2056-5933 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220565933%22">20565933 </searchLink><i>NLM ISO Abbreviation: </i>RMD Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41856561 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/rmdopen-2025-006329 Languages: – Code: eng Text: English Titles: – TitleFull: Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Holly T – PersonEntity: Name: NameFull: Kirkesaether Brun M – PersonEntity: Name: NameFull: Jørgensen KK – PersonEntity: Name: NameFull: Goll GL – PersonEntity: Name: NameFull: Sexton J – PersonEntity: Name: NameFull: Gehin JE – PersonEntity: Name: NameFull: Kvien TK – PersonEntity: Name: NameFull: Jahnsen J – PersonEntity: Name: NameFull: Provan SA – PersonEntity: Name: NameFull: Bolstad N – PersonEntity: Name: NameFull: Aas E – PersonEntity: Name: NameFull: Haavardsholm EA – PersonEntity: Name: NameFull: Kristiansen IS – PersonEntity: Name: NameFull: Syversen SW – PersonEntity: Name: NameFull: Hagen G IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 03 Text: 2026 Mar 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2056-5933 Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: RMD open Type: main |
| ResultId | 1 |
